Eli Lilly beats earnings expectations, raises guidance

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

United States Headlines News

United States Latest News,United States Headlines

Source: News Formal (newsformal.com)

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 3. in US

United States Latest News, United States Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Stocks making the biggest move premarket: CVS, Eli Lilly, Marriott, Mylan & moreSome of the names on the move ahead of the open.
Source: CNBC - 🏆 12. / 72 Read more »

Lilly says Taltz superior to Humira in late-stage psoriatic arthritis trialEli Lilly and Co said on Monday its psoriatic arthritis drug, Taltz, was found t... Do these pharmaceutical companies make drugs that cure disease or just reduce symptoms so they can sell more drugs? Should USDA be more robust in checking drug effectiveness for terminating illness?
Source: Reuters - 🏆 2. / 97 Read more »

Eli Lilly CEO on winning in migraine treatments: 'It's a horse race between three great companies'Jim Cramer and Eli Lilly CEO Dave Ricks speak about competition in the migraine treatment space and how Eli Lilly plans to win out. Gersen therapy already there long time ago - it cures migraine
Source: CNBC - 🏆 12. / 72 Read more »

Eli Lilly to acquire Loxo Oncology for about $8 billion
Source: CNBC - 🏆 12. / 72 Read more »

Loxo Oncology Inc.Loxo Oncology Inc. stock price, stock quotes and financial overviews from MarketWatch.
Source: MarketWatch - 🏆 3. / 97 Read more »

Eli Lilly to Buy Loxo Oncology in Deal It Values at About $8 BillionEli Lilly said it is buying Loxo Oncology for $235 a share—a 68% premium from Friday’s closing price—in cash, a deal that expands the biopharmaceutical company’s oncology-treatment portfolio. They got cash like that lying around? Cancer is a good business it seems. Can we get Universal Health Care please Wow.let's spread cancer to everyone Wonder how much the cost of insulin will soar to finance this gamble
Source: WSJ - 🏆 98. / 63 Read more »

Eli Lilly to buy Loxo Oncology in $8 billion cancer pushThe pharmaceutical company says it is buying Loxo Oncology for $235 a share in cash, a deal that expands the company’s cancer-treatment portfolio.
Source: trtworld - 🏆 101. / 63 Read more »

Eli Lilly to spend about $8B on Loxo OncologyEli Lilly is spending about $8 billion in cash to buy Loxo Oncology, as the drugmaker bulks up on cancer treatments that target certain gene abnormalities. Loxo Oncology could launch a drug next year and targets an abnormality that occurs in several tumor types, including some lung and... Hmm...Another Individual Attempting a Monopoly? If you want to know why we do not have a cure for cancer it is because this amount of money is exchanging hands. Treat not cure.
Source: ABC - 🏆 471. / 51 Read more »

Eli Lilly CEO: Loxo acquisition can help us treat cancer globally'This is the future of cancer treatment, we believe.' Eli Lilly CEO David Ricks said that Loxo Oncology has 'harnessed the power of emerging science' and that Lilly's acquisition of Loxo can help treat cancer globally. For a price Never gonna happen...they make too much money off of giving everyone cancer then all the treatments and pills.
Source: CNBC - 🏆 12. / 72 Read more »

Lilly eyes more cancer deals, but wary of CAR-T, gene therapyEli Lilly and Co remains in the hunt for cancer drugs even after announcing an $... I’m sure someone knows what that means.
Source: Reuters - 🏆 2. / 97 Read more »